// App-Quantinova.ai

TCT-29 : First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Researchers

Presenter

  • Robert J. Gil

Principal Investigators

  • Dobrin Vassilev

  • Jacek Bil

  • Luis A. Inigo-Garcia

Medical Centers

  • National Heart Hospital, Sofia, Bulgaria

  • Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland

  • Central Clinical Hospital of the Ministry of Interior, Warsaw, Poland

Locations

  • Poland

  • Bulgaria

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Stable coronary artery disease

  • Myocardial infarction

  • Hypertension

  • Venous thrombosis

  • Diabetes

Biomarkers

  • Tumor protein p63

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved